But an association with improved overall survival failed to reach statistical significance ...

A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...

Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...

Using de-identified data from the National Cancer Institute, researchers followed 205 patients—average age, 61 years—with prostate cancer and preexisting depression. Patients with both conditions had ...

A separate 2024 study in the Journal of the National Cancer Institute documented a dip in one-year survival for patients ...

Regarding site-specific survival, the authors broke down diagnoses into low-survival cancer sites or ...

CHICAGO -- A cheap, decades-old chemotherapy drug extended life by more than a year when added to standard hormone therapy for men whose prostate cancer has widely spread, doctors reported Sunday. Men ...

A Registrational Phase 2 clinical trial has been initiated in Japan for patients with PSMA-positive metastatic castration-resistant prostate ...

Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...

What key experiences or clinical gaps motivated your focus on advancing prostate cancer diagnostics, particularly MRI-led ...

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.